Ilka Netravali, MD
Dermatology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group
Looking this up.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Netravali’s office at (650) 498-7200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Texas T8898Physician License · since 2022 · expires 2028-08-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Money from drug and device companies
$81 in 2025
| 2025 | 3 | 4 | None | $81 |
| 2024 | 9 | 21 | $7,195 | $8,006 |
| 2023 | 11 | 71 | $15,550 | $17,456 |
| 2022 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Vijoice | $29 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $28 | 1 payment
|
| Pfizer | Cibinqo | $24 | 2 payments
|
See all 4 published payments
| Novartis Pharmaceuticals | Meals · 2025-12-02 | Vijoice | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-10-09 | Dupixent | $28 |
| Pfizer | Meals · 2025-04-07 | Cibinqo | $12 |
| Pfizer | Meals · 2025-03-18 | Cibinqo | $12 |
See earlier years (2024, 2023, 2022)
2024: $8,006
| Pfizer | Litfulo | $7,412 | 6 payments
|
| Novartis Pharmaceuticals | Vijoice | $253 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $110 | 4 payments
|
| Verrica Pharmaceuticals | None | $61 | 1 payment
|
| Genzyme | Dupixent | $47 | 2 payments
|
| Arcutis Biotherapeutics | Zoryve | $47 | 1 payment
|
| Incyte | Opzelura | $47 | 2 payments
|
| Krystal Biotech | Vyjuvek | $23 | 1 payment
|
| Mayne Pharma Commercial | None | $7 | 1 payment
|
2023: $17,456
| Pfizer | Litfulo | $13,120 | 15 payments
|
| Arcutis Biotherapeutics | None | $3,181 | 9 payments
|
| Genzyme | Dupixent | $478 | 23 payments
|
| Lilly USA | Olumiant | $253 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $154 | 8 payments
|
| Incyte | Opzelura | $110 | 2 payments
|
| Mayne Pharma Commercial | None | $49 | 4 payments
|
| Krystal Biotech | Vyjuvek | $35 | 2 payments
|
| Abbvie | Rinvoq | $35 | 2 payments
|
| Verrica Pharmaceuticals | Ycanth | $21 | 1 payment
|
| Galderma Laboratories L.P. | Aklief | $21 | 1 payment
|
2022: $23
| Abbvie | Rinvoq | $23 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| PFIZER INC. · Ritlecitinib Clinical Publication Program · 2025 | This clinician | $5,410 |
| PFIZER INC. · Abrocitinib Clinical Publication Program · 2024 | This clinician | $1,270 |
| PFIZER INC. · Litfulo Clinical Publication Program · 2024 | This clinician | $940 |
| PFIZER INC. · Ritlecitinib Clinical Publication Program · 2024 | This clinician | $330 |
Professional record
- NPI
- 1942658653
- Licence
- TX T8898Texas T8898: Active
- Trained
- Harvard Medical School, 2016
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207NP0225X (207NP0225X); Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2016-06-03
- NPI last updated
- 2024-07-01
- NPI record certified
- 2024-07-01
This is when the NPI record was last certified, not a medical board exam.